These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 14934836)

  • 1. [In vitro effect of various substances on Mycobacterium tuberculosis. I. Titration of streptomycin, aureomycin, PAS, caffeic acid, 5-nitro-2-furaldehyde-semicarbazone and salicylic acid in Dubos medium].
    TERNI M; ZANELLI QUARANTINI MG
    Boll Ist Sieroter Milan; 1951; 30(11-12):689-702. PubMed ID: 14934836
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro activity of various substance on Mycobacterium tuberculosis. II. Streptomycin aureomycin, PAS, caffeic acid, 5-nitro-2-furaldehyde-semicarbazone and salicylic acid; mechanism of action with reference to bacterial resistance].
    TERNI M; ZANELLI QUARANTINI MG
    Boll Ist Sieroter Milan; 1952; 31(1-2):55-74. PubMed ID: 14934844
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of action of associated PAS and streptomycin; bacteriological study in vitro].
    KITAMOTO O; RIST N
    Rev Tuberc; 1951; 15(10-11):950-6. PubMed ID: 14912808
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of anti-tuberculous antibiotics and drugs in vitro; comparative study on streptomycin, PAS, thiosemicarbazone succinci derivative, and isonicotinic acid hydrazide].
    INZERILLO R; CHITI E
    Arch Maragliano Patol Clin; 1952; 7(5):879-901. PubMed ID: 13017839
    [No Abstract]   [Full Text] [Related]  

  • 5. A quantitative analysis of the resistance of Mycobacterium tuberculosis to streptomycin, isoniazid and PAS.
    TSUKAMURA M; NODA Y; MIURA K
    Kekkaku; 1956 Feb; 31(2):107-10. PubMed ID: 13320628
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of combined treatment with streptomycin, PAS and isoniazid on resistance of Mycobacterium tuberculosis to streptomycin and isoniazid].
    JANKOV M
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1955; 7(1-4):228-34. PubMed ID: 13405406
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of para-aminosalicylic acid (PAS) on the development of resistance of tubercle bacilli to streptomycin.
    FRIEDMAN B; SALE L; GOLDMAN A
    Am J Med Sci; 1952 Jul; 224(1):53-6. PubMed ID: 14933413
    [No Abstract]   [Full Text] [Related]  

  • 8. The bactericidal activities of combinations of streptomycin, isoniazid, p-aminosalicylic acid (PAS), oxytetracycline (terramycin) and viomycin against Mycobacterium tuberculosis.
    SINGH B; MITCHISON DA
    J Gen Microbiol; 1955 Aug; 13(1):176-84. PubMed ID: 13252227
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effective tuberculostatic minimal concentration of streptomycin, conteben, PAS and neoteben in vitro and resistance phenomenon].
    WEIDMANN S; SAAME H
    Z Hyg Infektionskr; 1953; 136(6):579-86. PubMed ID: 13103314
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanism of action of para-aminosalicylic acid in preventing the emergence of resistance to streptomycin in mycobacterium tuberculosis.
    TSUKAMURA M
    J Antibiot (Tokyo); 1955 Dec; 8(6):196-200. PubMed ID: 13319223
    [No Abstract]   [Full Text] [Related]  

  • 11. [Streptomycin and PAS resistance of tubercle bacteria isolated from patients with tuberculous meningitis].
    VAN ZEBEN W; VAN GENDEREN H; MANTEN A
    Maandschr Kindergeneeskd; 1952 Apr; 20(3):69-83. PubMed ID: 14940043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of the effect of streptomycin with thio-semicarbazone and with paraaminosalicylic acid, and with two new paraaminosalicylic acid derivatives, in the treatment of experimental tuberculosis].
    MOESCHLIN S; DEMIRAL B
    Schweiz Med Wochenschr; 1950 Apr; 80(15):373-4. PubMed ID: 15413135
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the drug resistance in mycobacteria with genetic reference; on the frequency of appearance of PAS-resistant mutants in Mycobacterium tuberculosis var. hominis simultaneously resistant to streptomycin and isoniazid.
    TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):186-90. PubMed ID: 13385196
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synergistic action of streptomycin, PAS, viomycin, and neomycin on Mycobacterium tuberculosis in vitro in 11 various types of association].
    COLETSOS
    Rev Tuberc; 1951; 15(10-11):957-65. PubMed ID: 14912809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Practical viewpoints of resistance against streptomycin, PAS, conteben].
    UNHOLTZ K
    Tuberkulosearzt; 1952 Aug; 6(8):451-9. PubMed ID: 13005732
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fundamental experiments on combined effects of three anti-tuberculous agents, streptomycin, PAS and isoniazid. I. Studies mainly on the course of the resistance development of M. tuberculosis serially transferred in the cultural environment of three drugs used concomitantly].
    MIYAMOTO Y; UENO K
    Kekkaku; 1955 Nov; 30(11):659-63. PubMed ID: 13286850
    [No Abstract]   [Full Text] [Related]  

  • 17. Cultural properties of M. tuberculosis in resected pulmonary lesions of patients treated with streptomycin and para-aminosalicylic acid.
    GRANVILLE GE; JENKINS DE; COOLEY DA; DEBAKEY ME; WHITCOMB FC; HALPERT B
    Am Rev Tuberc; 1953 Nov; 68(5):727-33. PubMed ID: 13104885
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of resistance by Mycobacterium tuberculosis to streptomycin, viomycin, and paraaminosalicylic acid.
    JOSIUKAS A; ROY TE; BOYD G
    AMA Am J Dis Child; 1952 Dec; 84(6):747-8. PubMed ID: 12996007
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bacteriological studies on the resistance of Mycobacterium tuberculosis against streptomycin and other tuberculostatic drugs].
    POTHMANN FJ
    Ergeb Hyg Bakteriol Immunitatsforsch Exp Ther; 1955; 29():248-393. PubMed ID: 13241442
    [No Abstract]   [Full Text] [Related]  

  • 20. [A study on PAS-resistance; its relation to clinical symptoms and SM-resistance, the change of resistance in the course of treatment].
    ITO Y; KONDO H
    Kekkaku; 1955 Nov; 30(11):643-7. PubMed ID: 13286847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.